You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Novo Nordisk Articles
Popular Novo Nordisk Articles
Highly Recommended Novo Nordisk Articles
Send a link to this page to your friends and colleagues.
A series of new studies has shown that Prandin (repaglinide), a new oral antidiabetic drug, is effective in providing 24-hour control of blood glucose levels in people with type 2 diabetes. Prandin stimulates beta cells within the pancreas to produce insulin and is taken just before each meal, when insulin is needed. The drug reduces risk of hyperinsulinemia (excess insulin) or severe hypoglycemia (low glucose levels) by allowing insulin levels to return toward baseline between meals and at night.
Prandin was approved by the Food and Drug Administration in December 1997 and is marketed by Novo Nordisk.
Aug 1, 1998
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.